Treatment Adherence to Different Etanercept Regimens, Continuous vs. Intermittent, in Patients Affected by Plaque-Type Psoriasis

被引:11
|
作者
Esposito, Maria [1 ]
Gisondi, Paolo [2 ]
Cassano, Nicoletta [3 ]
Babino, Graziella [1 ]
Cannizzaro, Maria Vittoria [1 ]
Ferrucci, Giuliano [4 ]
Chimenti, Sergio [1 ]
Giunta, Alessandro [1 ]
机构
[1] Univ Roma Tor Vergata, Dept Dermatol, I-00133 Rome, Italy
[2] Univ Verona, Sect Dermatol & Venereol, Dept Med, I-37100 Verona, Italy
[3] Univ Bari, Unit Dermatol & Venereol, Dept Biomed Sci & Human Oncol, Bari, Italy
[4] Informa Srl, Rome, Italy
关键词
adherence; anti-tumor necrosis factor alpha (anti-TNF-); etanercept; psoriasis; DRUG SURVIVAL RATES; VULGARIS;
D O I
10.1002/ddr.21190
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Treatment adherence to anti-tumor necrosis factor alpha (anti-TNF-) agents is marker of treatment success, but overall efficacy of anti-TNF- therapy decreases over time leading to a progressive loss of adherence. The present observational study was conducted in order to estimate the long-term adherence to etanercept in patients affected by plaque-type psoriasis, evaluating differences among intermittent and continuous treatment regimen. Our findings reflect routine clinical practice in three academic referral centers and show high treatment adherence with etanercept in psoriatic patients. Treatment survival was consistently high in the short/medium term. The univariate analysis showed longer treatment duration in patients undergoing intermittent treatment regimen (mean 1,706days) compared with continuous regimen (mean 1,249days). Results showed that a flexible pulsed treatment with etanercept can be optimal in terms of clinical success and adherence.
引用
收藏
页码:S31 / S34
页数:4
相关论文
共 50 条
  • [1] CONTINUOUS TREATMENT OF PLAQUE-TYPE PSORIASIS WITH ETANERCEPT: AN OBSERVATIONAL LONG-TERM EXPERIENCE
    Esposito, M.
    Giunta, A.
    Mazzotta, A.
    Babino, G.
    Talamonti, M.
    Chimenti, M. S.
    Chimenti, S.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2010, 23 (02) : 503 - 509
  • [2] Efficacy and safety of infliximab in long-term treatment of plaque-type psoriasis: A comparative retrospective study on two different (continuous vs. relapse related) regimens
    Giunta, Alessandro
    Papoutsaki, Marina
    Bianchi, Luca
    Chimenti, Sergio
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (02) : AB190 - AB190
  • [3] A prospective randomized controlled trial comparing infliximab and etanercept in patients with moderate-to-severe chronic plaque-type psoriasis: the Psoriasis Infliximab vs. Etanercept Comparison Evaluation (PIECE) study
    de Vries, A. C. Q.
    Thio, H. B.
    de Kort, W. J. A.
    Opmeer, B. C.
    van der Stok, H. M.
    de Jong, E. M. G. J.
    Horvath, B.
    Busschbach, J. J. V.
    Nijsten, T. E. C.
    Spuls, Ph. I.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 176 (03) : 624 - 633
  • [4] An observational study to evaluate the long-term outcomes of treatment with etanercept in patients with plaque-type psoriasis
    Luger, T.
    Schopf, R. E.
    Schwanke, A.
    Langhammer, S.
    Meng, T.
    Loeschmann, P. A.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2016, 30 (10) : 1730 - 1741
  • [5] Synergism between narrowband ultraviolet B phototherapy and etanercept for the treatment of plaque-type psoriasis
    Calzavara-Pinton, P. G.
    Sala, R.
    Arisi, M.
    Rossi, M. T.
    Venturini, M.
    Ortel, B.
    BRITISH JOURNAL OF DERMATOLOGY, 2013, 169 (01) : 130 - 136
  • [6] INFLUENCE AND VARIATION OF THE BODY MASS INDEX IN PATIENTS TREATED WITH ETANERCEPT FOR PLAQUE-TYPE PSORIASIS
    Esposito, M.
    Mazzotta, A.
    Saraceno, R.
    Schipani, C.
    Chimenti, S.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2009, 22 (01) : 219 - 225
  • [7] A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis
    Menter, Alan
    Feldman, Steven R.
    Weinstein, Gerald D.
    Papp, Kim
    Evans, Robert
    Guzzo, Cynthia
    Li, Shu
    Dooley, Lisa T.
    Arnold, Cynthia
    Gottlieb, Alice B.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (01) : 31 - 44
  • [8] Transient paresis of the right recurrent laryngeal nerve after treatment with etanercept for plaque-type psoriasis
    Fiala, Katharina
    Schierl, Michael
    Breier, Friedrich
    Feldmann, Robert
    Sator, Paul G.
    EUROPEAN JOURNAL OF DERMATOLOGY, 2010, 20 (06) : 818 - 819
  • [9] Effectiveness and Safety of Etanercept in Paediatric Patients with Plaque-Type Psoriasis: Real-World Evidence
    Narbutt, Joanna
    Jakubczak, Zofia
    Wasiewicz-Ciach, Paulina
    Wojtania, Joanna
    Krupa, Katarzyna
    Sobolewska-Sztychny, Dorota
    Ciazynska, Magdalena
    Kolt-Kaminska, Marta
    Reich, Adam
    Skibinska, Malgorzata
    Lesiak, Aleksandra
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (16)
  • [10] Adherence of self-administered subcutaneous methotrexate in patients with chronic plaque-type psoriasis
    Vidal, D.
    Salleras, M.
    Romani, J.
    Ribera, M.
    Gallardo, F.
    Vinas, M.
    Xifra, A.
    Garcia-Navarro, X.
    Bordas, X.
    Ferran, M.
    Carrascosa, J. M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2016, 30 (11) : E131 - E132